the magnitude of risk due to these pollutants. For example, Although the risk for cancer is multifactorial, a substantial considerable attention has focused recently on the role of DDT portion of cancer incidence rates is related to environmental and other related environmental contaminants, which, acting factors, including diet and environmental chemicals. The as xenobiotic estrogens (xenoestrogens), are hypothesized to magnitude of the contribution to cancer of the breast from increase cancer risk (3,4). In contrast to pesticides, the phthalate exposure to environmental chemicals remains unclear. The esters are one of the most abundant of industrially-produced phthalate ester plasticizers are abundantly-produced induschemicals, that have become widely-dispersed environmental trial chemicals that have become widely-dispersed environpollutants. This group of chemicals is used to improve flexibilmental pollutants. The present studies were conducted to ity of plastic products. It has been reported that humans could determine the effect of the phthalate ester, benzyl butyl be exposed to them via contaminated soil and water, as well phthalate (BBP) on mammary gland carcinogenesis induced as food (5,6). Due to the widespread use of plasticizers in in the female rat by the polycyclic aromatic hydrocarbon wrappers, food has become a major route of exposure.
In the (PAH) 7,12-dimethylbenz[a]anthracene (DMBA). Exposure
United States, it has been estimated that the levels of phthalates to BBP (i.p. injection) at 100 and 500 mg/kg doses for 5 in foods can vary between 50-500 µg/kg. In Great Britain days resulted in a significant 72 and 92% inhibition, some confectionary products and snacks packaged with plastic respectively, in the in vivo formation of mammary DMBAwrap were reported to contain phthalate levels of 14 mg/kg DNA adducts, compared to controls. Treatment with BBP (7, 8) . During the past two decades, these compounds have (i.g. intubation) for 7 days resulted in a significant (48%) been evaluated for their potential to adversely impact on inhibition in mammary DMBA-DNA adduct formation only human health. Although phthalates appear not to be genotoxic, for those animals receiving the 500 mg/kg dose, compared to there has been evidence that at high concentrations they can controls. Administration of BBP (i.g.) at 500 mg/kg for 7 lead to testicular toxicity and embryolethality in rodents (9-days also was associated with a significant 8.5-fold increase 11). It has been suggested that the reproductive toxicity in the liver activity of 7-ethoxyresorufin-O-deethylase. No observed in female and male rats exposed to certain phthalates change in liver glutathione-S-transferase activity was partly may be due to an estrogenic effect (12,13). There is observed for animals treated with both BBP (i.g.) doses.
limited and inconsistent information on the role of these Treatment with BBP (i.g.) at 250 and 500 mg/kg doses phthalates in modifying the process of carcinogenesis. Certain for 7 days prior to DMBA administration resulted in a phthalates have been reported to enhance liver and skin significant 37% decrease in mammary tumor incidence for carcinogenesis in rodents, and to act as weak estrogens toward both doses, compared to controls. The number of mammary human breast cancer cells (12,14-17). Yet, others have observed adenocarcinomas per rat was significantly inhibited by 60 that exposure to a phthalate after initiation with a hepatoand 70% for rats exposed to BBP at the 250 and 500 mg/ carcinogen leads to an inhibition of preneoplastic lesions and kg doses, respectively, compared to controls. Therefore, the hepatocellular carcinomas (18,19). present studies indicate that BBP acts as a blocking agent
In light of the current concern about the role of environmental toward DMBA-induced rat mammary DNA adduct formation and mammary carcinogenesis. This effect partly may contaminants in enhancing breast cancer risk, the present be due to increased metabolism of BBP in the liver. These studies were conducted to determine the effect of a phthalate results underscore the need to further examine the effect ester, benzyl butyl phthalate (BBP*, Figure 1 ), on chemicallyof BBP and other phthalates on the various stages of induced rat mammary carcinogenesis. Three experiments were mammary carcinogenesis, as well as on the metabolism of conducted to examine the capacity of one group of contaminmammary carcinogens.
ants, represented by BBP, to influence mammary gland carcinogenesis induced in the female rat by another group of contaminants, polycyclic aromatic hydrocarbons (PAH), using Among American women, cancer of the breast is a leading 7,12-dimethylbenz[a]anthracene (DMBA) as a model. In the cause of cancer-related death. Although the risk for cancer is first two experiments, animals were treated with BBP at doses multifactorial, a substantial portion of cancer incidence rates of 100 or 500 mg/kg body wt via either intraperitoneal (i.p.) is related to environmental factors, including diet and environinjection (experiment 1) or intragastric (i.g.) intubation (experiment 2), in order to determine its capacity to affect the in vivo (14) . For experiment, because of the lack of effect of the 100 mg/kg experiment 1, BBP was administered i.p. to female Spraguedose in inhibiting adduct formation in experiment 2. Controls Dawley rats (x ϭ 144 g) daily (n ϭ 5/group) for 5 days prior were intubated with corn oil vehicle prior to DMBA dosing. to intubation with DMBA (i.g., 31 mg/kg in corn oil) at 50
Animals were weighed weekly and, beginning 5 weeks postdays of age. For experiment 2, BBP was administered i.g. to DMBA, were palpated weekly to determine mammary tumor female rats (x ϭ 144 g; n ϭ 6/group) daily for 7 days prior formation. At the termination of the experiment, tumors were to dosing with DMBA (i.g., 31 mg/kg in corn oil) at 50 days removed and classified histopathologically (23). For all three of age. For both experiments BBP was given in corn oil and experiments animals were fed a control, semipurified diet, controls received vehicle only. At 24 h after DMBA dosing in which contained the following ingredients (% by wt) as both adduct studies, mammary epithelial cell aggregate DNA recommended by the American Society for Nutritional Sciences was isolated and DMBA-DNA adducts quantitated by the 32 P-(AIN76A): vitamin-free casein (20), DL-methionine (0.3), sucpost-labeling procedure (20). Also, livers from the animals rose (25) , cellulose (5), AIN-76A vitamin mix (1), AINintubated with BBP were removed, and cytosolic and micro-76 mineral mix (3.5), cornstarch (37), choline dihydrogen somal fractions prepared for use in subsequent analyses of citrate (0.2) and corn oil (8). In general, animals were acclimglutathione-S-transferase (GST) activity (21) and ethoxyresoruated to this diet for at least 1 week prior to the beginning of fin-O-deethylase (EROD) activity (22), respectively.
experiments. Vitamin-free casein, mineral mix and vitamin In experiment 3, the effect of BBP exposure on the initiation mix were obtained from Teklad (Madison, WI). Edible-grade stage of DMBA-induced mammary carcinogenesis was evalucellulose, cornstarch, and sucrose were obtained from A.E.Staated. Female rats (x ϭ 141 g; n ϭ 27/group) were administered ley (Decatur, IL). BBP (98%) was obtained from Aldrich Chemicals (Milwaukee, WI).
In experiments 1 and 2, the administration of BBP to rats for 5 days by i.p. injection or for 7 days by i.g. intubation did not result in significant differences in growth compared to controls (Table I) . Treatment of animals with BBP by either route of administration was associated with a decrease in the formation of DMBA-DNA adducts in the mammary gland (Table I) . The injection of 100 and 500 mg/kg doses of BBP was associated with a significant 72 and 91% inhibition, respectively, in the quantity of total mammary DMBA-DNA adducts. The formation of both anti-and syn-derived adducts P ϭ 0.014; control versus 500 mg/kg BBP, P ϭ 0.009). By 15 weeks post-DMBA, mammary tumor incidence was was significantly depressed at both doses of BBP. When BBP was given i.g., there was a significant decrease in total decreased by 37% for rats treated with both doses of BBP, compared to controls. The number of palpable tumors per rat mammary DMBA-DNA adducts only for those animals receiving the 500 mg/kg dose (Table I) . BBP administered i.g. at at week 15 was significantly inhibited by 58 and 71%, for animals administered BBP at 250 and 500 mg/kg, respectively, 100 and 500 mg/kg doses was associated with a 25 and 48% decrease, respectively, in the quantity of total mammary compared to controls. In a similar manner, adenocarcinoma adducts, compared to controls. The quantity of anti-, but not syn-derived adducts was significantly less for animals treated with 500 mg/kg BBP, compared to controls.
Treatment of animals with BBP (i.g.) did not significantly influence the liver activity of GST per mg protein, although there was an increase in liver GST activity for rats receiving both doses of BBP (Table I ). The liver activity of EROD (a specific measure of cytochrome P4501A activity), was significantly increased following i.g. administration of BBP at 500 mg/kg (Table I) . EROD activity per mg protein was increased by 2.3-and 8.5-fold for animals treated with BBP at doses of 100 and 500 mg/kg, respectively.
In experiment 3, administration of BBP to animals for 7 days prior to DMBA dosing did not result in significant differences in animal body weights among groups. After 7 days of BBP treatment (i.g.), body weights (x) were 161.6, 162.5 and 160.8 g for rats in the control, 250 mg/kg BBP and 500 mg/kg BBP groups, respectively. There was no significant difference in body weights among treatment groups during the 15 weeks following DMBA administration (Figure 2 ). DMBAinduced mammary tumorigenesis was suppressed by treatment of animals with BBP prior to DMBA administration (Figure 3 , Table II ). Comparison of tumor incidence curves by survival analysis, using the generalized Wilcoxon test statistic to determine equality of survivor functions, indicated that treatment with both doses of BBP was associated with a significant decrease in tumor incidence (control versus 250 mg/kg BBP, DNA adducts and an increase in liver activity of EROD. These
